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Abstract 
Diabetes mellitus was a chronic disease that will suffer a lifetime. Educating the patient and family aims to 
provide an understanding of the course of the disease, prevention, and management and complications in 
patients with diabetes mellitus type 2. In this research, Glycemic Albumin (GA) was used as a marker of 
glycemic control associated factors increase treatment compliance and support families through the provision of 
education diabetes in patients with type 2 diabetes mellitus in Makassar and its surroundings. The general 
objective of this research was to determine the effect of education on glycemic control with Glycated Albumin 
as an indicator in patients with Type 2 Diabetes Mellitus.  The research type was quasy experimental. The 
research population was patients with Type 2 diabetes who follow treatment to various hospitals and polyclinics 
of Family Physician from the February 2015 until June 2015 in Makassar and its surroundings.  
----------------------------------------------------------------------- 
* Corresponding author.  
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The number of samples was 44 and sampling techniques was consecutive sampling technique, data was 
collected using a questionnaire Hensarling Diabetic Family Support Scale (HDFSS) and Morisky Medication 
adherence Scale (MMAS) made by officers while providing education about diabetes mellitus to the subject by 
way of meeting in the home of  subject once a week for 4 weeks. The results showed that at the end of the 
research changes the value of treatment compliance (MMAS) in the treatment group, the positive direction at a 
rate 3.5 times stronger than the control group. There were changes in the value of Family Support (HDFSS) was 
better than the control group, with positive direction and 2.7 times the rate of the treatment group compared to 
the control group. Decreased levels of GA on the subject of the treatment group than the control group (the 
control actually increased the mean). We suggest, Glycated Albumin (GA) can be recommended as an 
alternative parameter / indicator of glycemic control and as a diagnostic test Diabetes mellitus. Family support 
can give impetus to the clinician in the management of patients in order to provide treatment to avoid 
complications of diabetes mellitus. Similarly, treatment compliance can give encouragement to the clinician in 
order to provide treatment to avoid complications of diabetes mellitus. 
Keywords: Type 2 Diabetes mellitus; Glycated Albumin; Family Support; Treatment Compliance. 
1. Introduction  
The Research results of Basic Health (RISKESDAS) reported by the Ministry of Health in 2008 showed that the 
prevalence of diabetes in Indonesia amounted to 5.7% and in South Sulawesi reached 4.6% (Harela, 2013) [1]. 
Other researchers in Makassar explained that the DM in 1981 amounted to 1.5%, in 1989 amounted to 2.8%, 
and in 2005 amounted to 12.5%. According to WHO the number of people with diabetes in Indonesia will 
increase from 8.4 million (in 2000) to about 21.3 million people (2030) [1]. The high rate of morbidity, it makes 
Indonesia was ranked 4th in the world after China, India, United States [2]. 
The prevalence of DM in Indonesia increased from 1.5% to 2.3% (Soegondo and his colleagues, 2004). The 
prevalence can be estimated that the number of people with diabetes in 1994 was 2.5 million; In 1998 as many 
as 3.5 million; In 2000 there were 4 million which represents 6% of the adult population; In 2010 as many as 5 
million; In 2020 as many as 6.5 million. The largest increase will occur in 2030 as many as 21.3 million people 
with diabetes [2]. 
Educated patients can positively affect the outcome of the disease. Indeed, through education, patient may be: a) 
optimizing metabolic control, including self-monitoring of blood glucose or urine, dietary practices, 
administration of drugs, b) relieving symptoms of the disease or handle emergencies and exacerbation-related 
illnesses, c) preventing and managing complications such as micro complications and macrovascular, d) 
adopting a more positive attitude towards the disease, and e) supporting the doctor-patient relationship and plan 
of care, including follow-up [3]. 
Diabetes mellitus was a chronic disease that will suffer a lifetime. In the management of the disease, in addition 
to doctors, nurses, dietitians, and other health professionals, the role of the patient and family are very 
important. Educating to the patient and family aims to provide an understanding of the course of the disease, 
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prevention, complications, and management of diabetes, will help increase family participation in efforts to 
improve the result of management [4]. A family function and treatment compliance were strongly associated 
with metabolic control. The results of demographic information indicates that these two factors accounted for 
49% of the variation of metabolic control [5]. 
The Controlling glucose effectively and successfully requires the continously use of effectively drugs. 
Morbidity and mortality as a result of micro and macrovascular complications in type 2 diabetes, provide 
financial costs surprisingly, both individuals and for society [6]. 
Compliance with anti-hyperglycemic drug has been proven as a key strategy in achieving long-term blood sugar 
control. Noncompliance treatment in patients with type 2 diabetes mellitus has been shown to reduce the 
effectiveness of therapy, increase the risk of hospitalization and mortality [7]. Whatever the chosen word, it is 
clear that the full benefits of many effective medications available will be achieved only if the patient follows 
the proper prescribed treatment regimen pretty well [8]. 
Adherence levels are usually higher among patients with acute conditions, compared to those with chronic 
conditions, persistence among patients with chronic conditions is low, the most dramatic decline after the first 
six months of therapy [9]. 
Basically, The control blood glucose levels in patients with type 2 diabetes mellitus was determined by 
treatment regimens and patient compliance taking the drug [10] With the standardization of treatment on 
patients with type 2 diabetes will mean a single only affecting control glucose levels in the blood was the patient 
compliance in the treatment of diabe type 2 diabetes mellitus [10]. 
In studies that have been conducted about the compliance of treatment was influenced by a number of factors 
that can be grouped into four categories: knowledge, attitude, support, and background. Some of these factors 
will have a major impact on adherence, while others may only have a minimal effect. The factors are grouped in 
this way, it will likely be used to intervene to reduce non-compliance [10]. 
Measuring the level of compliance with the respondents were also conducted using questionnaires of Morisky 
Medication adherence Scale (MMAS) -8. MMAS was the assessment tool from the WHO that has been 
validated and often used to assess patients' adherence to treatment, especially for chronic diseases such as 
Diabetes Mellitus. This questionnaire is a revision of the MMAS-4 that has a higher sensitivity and specificity, 
at 93% sensitivity and 53% specificity in assessing the level of adherence to treatment [11]. 
The Family support to adult patients with DM  provide benefits in the management and adjustment to illness. 
The Research conducted in 66 patients with type 2 diabetes who have come to control to the Polyclinic Hospital 
Marmira City Kacaeli Turkey, social support (one of which is the family) and quality of life improved together, 
In this research it can be concluded that social support can improve quality of life, so that health professionals 
must develop a strategy to improve social support for patients, especially from the family. Assessment of family 
support in diabetic patients can help in determining individual objectives and intervention strategies in 
improving patient self-management of DM to improve metabolic control and psychosocial adaptation of the 
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Diabetes Mellitus [11]. 
The concept of Diabetes Family Support (DFS), defined as how patients with diabetes see their family support. 
The Family support is very important in helping a person who planned care and treatment diabetes. With that, 
the one can see the importance of support for a well-managed disease. According to A Cure Curriculum for 
Diabetes Education by the American Association of Diabetes Educators,  the main influence of social support on 
diabetes self treatment of adults in his life by through a spouse, other family members, friends, and coworkers 
[12]. 
A family function and treatment compliance attitude were very influential in healthy. The assessment status at a 
family function with diabetes and then added with treatment compliance were an important factor in 
understanding the metabolic control [5]. 
For over 25 years, hemoglobin A1c (HbA1c) has been the result of measurement that widely accepted to assess 
glycemic control in individuals with diabetes. This test gives an average index of the patient's blood glucose 
over the past 2-3 months and considered the most objective and reliable measurement for long-term metabolic 
control. Diabetes Control and Complications Trial conducted to maintain HbA1c levels as close to normal as 
causing a decline in long-term health complications [13,14]. Then, as the "gold standard" measure of diabetes 
control, these tests provide important feedback to health workers and patients. It gives an understanding of the 
patient to the test and its implications for long-term health [14]. 
Meta-analysis of Norris and his colleagues indicates that the effect of education on diabetes seen in glycemic 
control. Author identified 31 articles from 1980 to 1999 to evaluate the handling efiksasi to the education in the 
controlling glikohemoglobin at adults with diabetes type 2. In a meta-analysis, the author state that "On average, 
the intervention glikohemoglobin decreased by 0.76% (95% confidence interval, 0,34-1.18) more than the 
control group at 1 to 3 months period of education. An additional finding of this research that glikohemoglobin 
"more decreased with additional contact time between participants and educators; a decline 1% recorded for 
each additional 23,6 hours (13.3 to 105.4) contact. The increase of glikohemoglobin causes an increase in 
HbA1c [15]. 
The Several studies have demonstrated compliance with treatment aimed at reducing HbA1c value. The HbA1c 
Value 1.0% lower apparently associated with reduced risk of microvascular complications by 25% with an 
absolute risk of HbA1c values below 7.5%. Association for the Study of Diabetes and the American Diabetes 
Association recommends that optimal value of HbA1c values for Diabetes Mellitus was <6.5% [15].  
Good glycemic control was associated with reduced complications DM. It was important for the patient to 
understand these tests and the longer-term implications [16]. 
The GA Measurement also affected by half serum albumin. The Increased turnover serum albumin result in 
lower levels of GA in relation to glycemia and GA level and otherwise the serum might be higher in conditions 
of decrease in albumin. Therefore, GA serum levels should be interpreted with caution in cases with disorders 
show normal albumin, such as nephrotic syndrome, hypothyroidism, hyperthyroidism and liver cirrhosis (Koga 
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M and his colleagues, 2010) .HbA1c is the standard measure used to monitor long-term (2-3 months) glucose 
control in diabetics, and currently now used for the diagnosis of diabetes. Glycated albumin is a marker of short-
term (2-4 weeks) glycemic control and it can be added complementary prognostic information of HbA1c [17]. 
Furthermore, Morisky Medication Scale also has been widely used as instruments tend to measure the level of 
treatment compliance and Hensarling Diabetes Family Support Scale to family support, therefore, the author are 
interested in doing research related to the development of factors adherence and support families through the 
provision of diabetes education for control blood glucose levels by measuring GA in patients with type 2 DM in 
Makassar. 
2. Materials and Methods  
The research model used was a quantitative research, using a type of experimental research. The design used 
was an experimental quasy. Model approach used were the subject of pre-test and post-test. 
The population of research was patients with Type 2 diabetes who visited a variety of Family Physicians Clinic 
who become BPJS participants in the research period in 2015. Part of this population who have met the criteria 
and the corresponding length of time the sample were selected as the research sample.  
The number of samples of this research are 44 people corresponding calculation of sample size and sampling 
technique used was the technique of consecutive sampling, data was collected using a questionnaire Hensarling 
Diabetic Family Support Scale (HDFSS) and Morisky Medication adherence Scale (MMAS) were used to 
collect data support family and patient treatment compliance and HDFSS and MMAS were used as a tool in 
determining educational materials that expected to occur improvement of family support and treatment 
compliance and GA levels among respondents with type 2 diabetes. 
Total Sample were 44, with the youngest sample was 38 years old and the oldest  sample was 75 years old. The 
average age of the respondents 54 years with a standard deviation of 7.789. Seven from every 10 samples were 
women and only 3 per 10 samples were male. 
3.  Research Results  
3.1 Inter-variable analysis 
3.1.1 First Part 
For a limited review and to simplify the analysis, scores related MMAS and HDFSS were variable with a scale 
measuring anisomorf (ordinal) and considered to have units isomorfi, thus serving the data shown mean and SD 
despite realizing the  greater limitations in interpreting the true meaning (in the calculation of probabilities 
remain non-parametric tests were used according ordinal scale of measurement).  
Looked GA at initial of research did not differ significantly between treatment with control, the same thing also 
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happened in the final condition (ga2). 
Table 1: The Comparison of Average GA Value Based Group 
Group Statistics 
 Groups N Mean Std. Deviation  P 
GA1 Treatment 22 32.1933 9.55037 0,074 
Control 22 27.2391 8.37959  
GA2 Treatment 22 27.7513 9.83976 0.567 
Control 22 29.3077 9.61168  
      
VELOGA Intervention 22 -12.5605 14.76962 0.001 
 Control 22 7.4874 21.73324  
Analysis by Independent t test 
The mean GA at the beginning doesn`t differ significantly (so that the intervention group and the control group 
were considered equivalent).  
At the end of the observation found the average difference GA levels between the two groups was not 
significant. In the treatment group decreased levels of GA until 13.7% and in the control group increased GA 
levels until 8.6% from beginning values. A gap between the rate of the group treated with control of 22.3% (-
13.7% to + 8.6%) which logically can be regarded as profits intervention. 
Tentative conclusions: there was the effect of treatment against reduced of GA levels at research subjects than 
controls (on the control actually increased the mean). 
Table 2: Comparison of Average Value MMAS and Rate Based Group 
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Analysis by Mann Whitney U test 
Similarly GA, the median value in the treatment group and the control from aspects of Medication adherence 
Morisky Value Scale (MMAS) in the initial phase did not differ significantly (p = 0.079) and in the final phase, 
the two groups differed median (p = 0.040). MMAS in the end of research differ significantly between the 
treatment and control group despite both treatment and control increased.  
The final point score achieved by treatment group was 5.362, while the control was only 4.341, both of the 
directions were positive  but Velocity or rate of change MMAS (defined by (MMAS2-MMAS1) / MMAS1 in 
units per cent) were found differ significantly in both groups at a rate high enough on treatment until 118.723% 
where in control group was only 33.591%.. The speed rate was 3,534 times stronger than the control group. 
Tentative conclusions: the treatment of different gives positive effects on the score MMAS and more powerful 
than the untreated group (control), the positive direction at a rate was  3.5 times compared to the control. 
Table 3: Comparison of Average Value Variable HDFSS and rate Based Group 
 Groups N Mean Std. Deviation P 
HDFSS1 Treatment 22 64.3182 13.99451 0./897 
Control 22 64.9091 13.79409  
HDFSS2 Treatment 22 81.2727 12.50212 0.015 
Control 22 71.3636 12.32321  
VELOHDFSS 
Treatment 
22 29.6757 25.65998 0.014 
Control 22 11.1657 10.93410  
Analysis by Mann Whitney U test 
The Family support in early phase between the treatment group and the controls were similar (median 22.5 to 
the treatment and 22.75 to the control.  
The P value 0.897). After treatment there was a change in the group treated with increasing of family support 
(median 27.23) while in control group, there was decreasing support controls (median of 17.77). The two groups 
differed significantly (p = 0.015), which standardized by using a percentage rate shows scores HDFSS drove 2.7 
times in the treatment group compared to the control. 
Tentative conclusions: the treatment effect better on HDFSS score than control, with positive direction and the 
rate of 2.7 times compared to the control. 
3.1.2 Second Part 
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3.1.2.2 The Special Analysis of Treatment and Control Groups 
Table 4: Special Analysis of Treatment Group 
Wilcoxon Signed Ranks Test 
  
N 
Average (Mean 
Rank) Sum of Ranks 
GA2 - GA1 Better (Negative Ranks) 22(100,00%) 11.50 253.00 
Worse (Positive Ranks) 0b .00 .00 
Ties (No Changes) 0c   
Total 22(100,00%)   
MMAS2 - 
MMAS1 
Worse (Negative Ranks) 0d .00 .00 
Better (Positive Ranks) 22(100,00%) 11.50 253.00 
Ties (No Changes) 0f   
Total 22(100,00%)   
HDFSS2 - 
HDFSS1 
Worse (Negative Ranks) 1(4,55%) 4.00 4.00 
Better (Positive Ranks) 21(95,45%) 11.86 249.00 
No Changes (Ties ) 0i   
Total 22(100,00%)   
 
a. GA2 < GA1 
b. GA2 > GA1 
c. GA2 = GA1 
d. MMAS2 <MMAS1 
e. MMAS2 >MMAS1 
f. MMAS2 = MMAS1 
g. HDFSS2 < HDFSS1 
h. HDFSS2 > HDFSS1 
i.  HDFSS2 = HDFSS1 
Wilcoxon Signed Ranks Test Rank: 
In GA2-GA1 from N = 22, gain mean rank negative as much as 11.50, where the total rank is 253.00, indicating 
GA2 <GA1. There was no value for the positive ranks was GA2> GA1. All these values indicate that GA2 
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<GA1 and none grades ties (equal between the initial and final value). The test values found p = 0.000, 
conclusion: there was a decrease in the value of GA1 from GA2 significantly as a result of treatment. 
In MMAS2-MMAS1 there were no negative ranks and vice versa, obtain positive rank as 11.50, with a total of 
253.00, indicating the results of MMAS2> MMAS1, there are no ties, significance value = 0.000. Conclusion: 
The treatment causes a change in the MMAS significantly. 
In HDFSS 2 - HDFSS 1 gain only one negative rank, with a mean rank 4.00 per case, which signifies HDFSS2 
<HDFSS1. Positive rank as many as 21, with a mean of 11.86 indicating rank HDFSS2> HDFSS1. Ties are not 
obtained. Value test results p = 0.000, Conclusion: the treatment causes changes in HDFSS positively and 
significantly from the initial conditions to final conditions. 
Table 5: Special Analysis of Control Group 
 
 
a. GA2 < GA1  
b. GA2 > GA1 
c. GA2 = GA1 
d. MMAS2 <MMAS1 
e. MMAS2 >MMAS1 
f. MMAS2 = MMAS1 
g. HDFSS2 < HDFSS1 
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h. HDFSS2 > HDFSS1 
i. HDFSS2 = HDFSS1 
Test Statisticsb 
 GA2 - GA1 MMAS2 - MMAS1 HDFSS2 - HDFSS1 
Z -2.029a -3.271a -3.826a 
Asymp. Sig. (2-tailed) .042 .001 .000 
a. Based on negative ranks. 
b. Wilcoxon Signed Ranks Test 
 
 
In GA2-GA1, from N = 22, there are 7 people (31.818%) get mean rank negatively on the ratings 9.14, where 
the total rank was 64.0 (compared with the similar condition to treatment with 22 people or 100% down to the 
total rank 253.00). There were 15 people who experienced a ratings increase (68.182% with a median score of 
9.05 and the total score of 12.60 and a total ratings of 189). None grades ties (equal between the initial and final 
value). 
The test Values found p = 0.042, conclusion: there was a change in the value of GA2 from GA1 significantly in 
the control (different direction from the treatment). 
In Morisky Medication adherence Scale (MMAS) MMAS2-MMAS1 there was one sample (4,545%) negative 
ranks from median of 8,000 and total 8.000. Sample in control group consist of positive rank with 16 people 
(95.455%) with a median 9:06, with total reach 145.00, 5 people ties, a significant value of p = 0.001. 
Conclusion: there are significantly change of MMAS in the control group. 
Family support as measured by a score HDFSS sample with negative rank of 0. Positive rank as many as 19 
people (86.364%) median of 10 with a total of 190, ties obtained 3 people (13 636%). Value test results p = 
0.000, conclusion: the control group experienced a positive and significantly change in HDFSS from the initial 
conditions to final conditions. 
4. Discussion  
4.1 The Level and Dynamics Analysis of the Average GA Value Based Group 
At the initial research, the level of GA initial conditions (GA1) seems not significantly different between 
treatment groups and the control group, the same thing also happened in the levels of GA on the final conditions 
(ga2). 
In the independent t test, mean GA at the beginning doesn`t differ significantly (so that the intervention group 
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and the control group were considered equivalent). At the end of the observation found the average difference 
GA levels between the two groups was not significant. In the treatment group levels of GA decreased until 
13.7% and in the control group GA level increased until 8.6% from baseline values. A gap between the rate of 
the group treated with control of 22.3% (-13.7% to + 8.6%) which logically can be regarded as profits 
intervention. This means there was a treatment effect (Education) to decrease the levels of GA in research 
subjects while in the control group , there are increased the mean. 
Glycated albumin (GA) are known to reflect short-term glycemic levels, and could be a monitor DM therapy for 
age albumin (17 days) shorter than erythrocytes (28 days) [18, 19]. 
The several studies have shown that GA better monitor DM also a better marker of glycemic control than 
HbA1c in patients who undergoing hemodialysis also in patients with type 2 diabetes or poorly controlled 
fluctuate. In addition, serum GA was not affected by factors that affect metabolism hemoglobin.7 The 
International Expert Committee (IEC) has recently proposed a new diagnostic criteria based on the measurement 
of HbA1c. 
However, little attention was focused on estimating the ability of GA compared with HbA1c in diagnosis of 
DM. However, the ability test of GA was not widely available and it was not standard. Thus, there was little 
data to show that the GA will be useful as a diagnostic tool. 
In a cross-sectional research aims to establish the validity of the GA as glycemic control and evaluate its utility 
as a diagnostic tool for diabetes in community-based population  [18, 19]. 
4.2 The correlation between GA and PG or HbA1c 
There was a positive and significant correlation of serum GA with FPG (Figure 1a: r = 0.8097, p <0.0001) and 
HbA1c (Figure 1b: r = 0.8976, p <0.0001). Similarly, there are positive and significant correlations of GA was 
also found with PG (Figure 1c: r = 0.6545, p <0.0001) 2 hours after the initiation of a 75 g TTGO, which did not 
differ significantly from the HbA1c with FPG (r = 0.8259, p <0.0001) and 2 - h PG (r = 0.7142, p <0.0001), 
based on the lack of a significant difference in the value of r. The analysis of regression showed there are no 
correlation between GA and other biochemical measurements in our research. Thus, GA correlate better with 
FPG than with 2h - PG, whereas HbA1c showed similar correlations with both FPG and 2h - PG. 
4.3 The characteristic Performance of GA for DM undiagnosed 
Figure 2 shows the ROC analysis for GA in predicting undiagnosed diabetes among 1,211 people. AUC ROC 
curve for GA (confidence interval, 0.861 (95% (CI); 0.787 to 0.917)) with a cut-off point of 15.7% predicting 
undiagnosed diabetes is similar to the FPG (0.882 (95% CI; 0.812 -0.934)) and HbA1c (0.861 (95% CI; 0.812- 
0.934)). According to ROC analysis, cut-off point for the best prediction of GA to the DM was 15.7%, with 
73.3% sensitivity and 80.1% specificity. 
The researcher tested the significance of GA as an indicator in the diagnosis of diabetes mellitus, relating with 
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FPG PG at the end of the two-hour 75-g TTGO. 2h-PG after initiation of TTGO correlate with GA unlike in 
HbA1c. GA correlate with FPG than with 2h-PG, whereas HbA1c shows similar correlation with both of FPG 
and 2h-PG. Overall, we found a very positive correlation between GA level  and HbA1c (r = 0.898) and FPG (r 
= 0.810). The correlation coefficient was equal to that reported by previous studies. 
The ROC analysis showed that the value of GA 15.7% represents the best value for distinguishing patients with 
diabetes than those who did not, with a 73,3% sensitivity and a 80,3% specificity The area under the ROC curve 
was 0.861. These data support the contention that the GA was a reasonable marker for the diagnosis of diabetes 
in a medical evaluation. Although, in this case, its performance was similar to the use of HbA1c, but there are 
other advantages to be gained from measurements GA. For example, GA has an advantage compared HbA1c in 
some cases, because it reflects the level of GA average for 2-3 previously weeks. 13 So, it was better as a 
potential monitor glycemic control for patients with diabetes who suffer from severe fluctuations in their 
glucose levels. It can also be used to confirm the treatment effect when starting or changing medications. 
The Japan Society of Clinical Chemistry (JSCC) has reported a recommended method for the measurement of 
serum. But International Standarization for GA was clearly needed if this test becomes widely used. The 
Lucica® GA - L enzymatic kit that we used in this research has been automated high throughput analysis, and 
more suitable for such analysis than HPLC or other liquid chromatography method 
5. Conclusion 
5.1 The Effect of Educaton against the Compliance of Treatment 
The median value in the treatment group and the control from the aspects of Medication adherence Morisky 
Value Scale (MMAS), or treatment compliance in the initial phase did not differ significantly (p = 0.079) and in 
the final phase, the two groups differed median (p = 0.040). MMAS at the end of the research differ 
significantly between treatment groups and control despite treatment and control both increased. The final point 
score achieved by treatment group was 5362, while the control was only 4,341, both of the directions was 
positive but Velocity or rate of change MMAS (defined by (MMAS2-MMAS1) / MMAS1 in units per cent) 
were found differ significantly in both groups at a rate high enough on treatment to 118. 723%  and in control 
group was only 33.591%.  The pace of the treatment group was 3,534 times stronger than the control group. 
Conclusion The treatment groups influence different positive on the value of treatment compliance (MMAS) 
and more powerful than the untreated group (control), the positive direction at a rate of 3.5 times compared to 
the treatment groups. 
5.2 The effect of education against the family support 
The Family support in the early phase between the treatment group and the controls group were similar (median 
22.5 to treatment and 22.75 to the control. The P value 0.897). After trreatment there was change in the 
treatment group with increasing family support (median 27.23) while in control group, there are decreasing 
support of family (median of 17.77). The two groups differed significantly (p = 0.015), which standardized 
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using cent rate shows scores HDFSS drove 2.7 times in the treatment group compared to the control group. 
Conclusion The treatment group to influence better the value of Family Support (HDFSS) than the control 
group, with positive direction and the rate of treatment group was 2.7 than the control group. 
5.3 The effect of education to Glycated Albumin 
The mean GA at the beginning does not differ significantly (so that the intervention group and the control group 
were considered equivalent). At the end of the observation found the average difference GA levels between the 
two groups was not significant. In the treatment group, levels of GA decreased until 13.7% and in the control 
group, increased GA levels until 8.6% from baseline values. A gap between the rate of the group treated with 
control of 22.3% (-13.7% to + 8.6%) which logically can be regarded as profits intervention. 
Conclusion There are no effect of treatment to the decline level of GA in the subject compared to the control 
group (the control actually increased the mean). 
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